Answers are grounded in this paper and cite their sources.
Aglatestine A ( 1 ), an unprecedented 3/6/6 tricarbocyclic limonoid framework along with four biogenic A/D- seco limonoid analogues with rare β-substituents at C-6 ( 2–5 ), was discovered from the fruits of Aglaia edulis . The structures of 1–5 along with their absolute configurations were clarified using methods of HRMS(ESI), NMR, electronic circular dichroism, X-ray diffraction crystallography, and quantum chemical calculations. The plausible biogenetic speculation suggested that an electrophilic cyclization between C-1 carbocation from acetolysis and electron-rich C-5 from enolization of C═O of 2 may play a key role. The biological evaluation showed that 5 exhibited anti-inflammatory activity indicated by inhibiting NO release in LPS-activated RAW 264.7 macrophages (IC 50: 35.72 ± 1.96 μM).
No takes yet. Share an insight, caveat, or question.
Sun et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: